Your session is about to expire
← Back to Search
Neuropsychological and Behavioral Testing in Younger Patients With Cancer
N/A
Waitlist Available
Led By Leanne M Embry
Research Sponsored by Children's Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This research trial studies neuropsychological (learning, remembering or thinking) and behavioral outcomes in children and adolescents with cancer by collecting information over time from a series of tests.
Eligible Conditions
- Childhood Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Observational (neuropsychological and behavioral tests)Experimental Treatment2 Interventions
Parent and child participants complete the COG Standard Neuropsychological and Behavioral Battery at approximately 9, 30, and 60 months post-diagnosis in a 1-2 hour testing session conducted by a neuropsychologist or psychologist. The Battery consists of measures of intelligence, processing speed, attention, memory, language preference, behavioral/social/emotional function, executive function, adaptive function, and quality of life.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Assessment
2011
Completed Phase 2
~1420
Find a Location
Who is running the clinical trial?
Children's Oncology GroupLead Sponsor
460 Previous Clinical Trials
238,798 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,950 Previous Clinical Trials
41,110,395 Total Patients Enrolled
Leanne M EmbryPrincipal InvestigatorChildren's Oncology Group